Navigation Links
Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets
Date:9/22/2011

NEW YORK, Sept. 22, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets

http://www.reportlinker.com/p0619263/Global-Markets-for-Contract-Pharmaceutical-Manufacturing-Research-And-Packaging-Focus-on-Emerging-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Manufacturing

REPORT HIGHLIGHTS

* The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion in 2011 and is projected to reach at $360.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.6%.

* The Rest of World (ROW) and emerging markets had revenue of approximately $10.5 billion in 2010, which increased to $11.2 billion in 2011 in the bulk drugs/API market. The revenue of this market is expected to rise to $15.5 billion in 2016, with the CAGR expected to rise at 6.7%.

* The ROW market for contract manufacturers that produce solid dosage forms including tablets and capsules had revenue of $2.9 billion in 2010. The ROW market revenue for the solid dosage form is projected to reach $7 billion by the end of 2016 while increasing at a CAGR of 15.5%.

INTRODUCTION

STUDY OBJECTIVE

The objective of BCC Research in conducting this study is to provide an overview of the current situation and future capabilities of the global pharmaceutical contract manufacturing, research, and packaging markets. The study provides a global as well as a regionally specific market overview. The report emphasizes the current and future outlook of the pharmaceutical contract manufacturing market, with a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry.

The current report discusses and outlines the current capabilities as well as the needs of the pharmaceutical contract manufacturing, research, and packaging markets. In addition, it discusses company and market strategies to further enhance the market. The report includes the different types of contract manufacturing and, more specifically, the services offered by global contract manufacturers, researchers, and packagers. The report also discusses the methods best used to identify an effective contract manufacturer as well as the advantages of contract manufacturing and outsourcing. The REPORT HIGHLIGHTS the need for project management, provides market forecasts for different aspects of contract manufacturing specific to each region, and examines the role of market leaders in the industry. Regulatory requirements and new developments in the market are also discussed in the report.

The report encompasses the revenues gained from contract manufacturing in each specific market and in each specific region. Sales analysis was performed on specific categories of drugs and dosage forms including API/bulk drugs and solid, liquid, and semisolid dosage forms. Sales analyses were also performed on revenues gained from contract packaging and contract research. The sales figures discussed are for the examined period of 2009 to 2011. Sales figures were also forecast for the following 5-year period from 2011 through 2016.

Over-the-counter (OTC) drugs, nutritional drugs, and drug delivery products are discussed in a separate section of this report.

REASONS FOR DOING THIS STUDY

The majority of pharmaceutical companies are now using contract manufacturing, research, and packaging services. To save costs and product development time while simultaneously being effective, efficient, and productive, pharmaceutical companies are relying on contract manufacturers to fulfill many basic as well as specialized competencies. This study discusses the different types of contracting companies, their roles, and the share of the market they claim. New developments and new technologies warrant the issuing of this report, which is an important resource for anyone analyzing the discussed markets.

Trends in outsourcing and new emerging markets for outsourcing are providing a new look to the market and greater options to pharmaceutical companies. The industry is seeing an increase in outsourcing as contract manufacturers, researchers, and packagers provide cheaper options as well as region-specific suppliers. The new state-of-the-art packaging facilities as well as expensive research facilities and capabilities of research organizations are enhancing the overall growth of the contract manufacturing industry. Contract manufacturers are providing pharmaceutical companies with expertise in all forms that the companies do not have available in-house.

INTENDED AUDIENCE

This study examines the areas of market growth in pharmaceuticals contract manufacturing, research, and packaging from the point of view of manufacturers and users. Strategic decision makers at biochemical and biotechnology companies, physicians, pharmaceuticals and biopharmaceuticals companies, and related research companies will find value in this study.

SCOPE OF THE STUDY

The scope of this study encompasses the contract manufacturing, research, and packaging markets. BCC analyzes each market and its applications for contract manufacturing by its need for outsourcing, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical, chemical, pharmaceutical, and contracting experts. Market sizing estimates and projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of pharmaceuticals through contract manufacturing and research. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

CHAPTER ONE: INTRODUCTION 1

STUDY OBJECTIVE 1

REASONS FOR DOING THIS STUDY 1

INTENDED AUDIENCE 2

SCOPE OF THE STUDY 2

METHODOLOGY 2

INFORMATION SOURCES 3

ABOUT THE AUTHOR 3

RELATED BCC RESEARCH REPORTS 3

BCC ONLINE SERVICES 4

DISCLAIMER 4

CHAPTER TWO: SUMMARY 5

SUMMARY 5

SUMMARY (CONTINUED) 6

SUMMARY TABLE GLOBAL PHARMACEUTICAL CONTRACT

MANUFACTURING AND CONTRACT RESEARCH

ORGANIZATIONS REVENUE, THROUGH 2016 ($ BILLIONS) 7

SUMMARY FIGURE GLOBAL PHARMACEUTICAL CONTRACT

MANUFACTURING AND CONTRACT RESEARCH

ORGANIZATIONS REVENUE, 2009-2016 ($ BILLIONS) 7

CHAPTER THREE: OVERVIEW 8

DEFINITIONS 8

DEFINITIONS (CONTINUED) 9

HISTORY OF OUTSOURCING 10

TABLE 1 KEY DEVELOPMENTS IN THE HISTORY OF

OUTSOURCING 10

TABLE 1 (CONTINUED) 11

CHAPTER FOUR: OVERVIEW OF CONTRACT MANUFACTURING 12

TYPES OF CONTRACT MANUFACTURERS 12

CONTRACT MANUFACTURING TRAITS 12

REQUIREMENT 12

ABILITY TO BE FLEXIBLE 13

CAPABILITIES WITHOUT COST 13

ADVANTAGES AND DISADVANTAGES OF CONTRACT

MANUFACTURING 13

TABLE 2 KEY ADVANTAGES OF CONTRACT MANUFACTURING 14

TABLE 3 KEY DISADVANTAGES OF CONTRACT MANUFACTURING 14

SELECTING A CONTRACT MANUFACTURER 14

TABLE 4 KEY FACTORS IN SELECTING A CONTRACT

MANUFACTURER 15

TABLE 4 (CONTINUED) 16

ADDITIONAL FACTS ABOUT CONTRACT MANUFACTURING 16

LOCATION AND PROXIMITY 16

AFTER-SALES SUPPORT 16

CHAPTER FIVE: OVERVIEW OF CONTRACT RESEARCH 17

OVERVIEW OF CONTRACT RESEARCH 17

SERVICES OFFERED BY CONTRACT RESEARCH

ORGANIZATIONS 18

TABLE 5 SERVICES OF CONTRACT RESEARCH ORGANIZATIONS 18

TABLE 5 (CONTINUED) 19

SELECTING A CONTRACT RESEARCH ORGANIZATION 19

TABLE 6 KEY CHARACTERISITCS IN SELECTING A CONTRACT

RESEARCH ORGANIZATION 19

TABLE 6 (CONTINUED) 20

RESEARCH PROVIDED BY CONTRACT RESEARCH

ORGNIZATIONS 20

TABLE 7 TYPES OF RESEARCH PROVIDED BY CONTRACT

RESEARCH ORGANIZATIONS 20

TABLE 7 (CONTINUED) 21

CHAPTER SIX: OVERVIEW OF CONTRACT PACKAGING 22

NEEDING A CONTRACT PACKAGER 22

TABLE 8 REASONS BEHIND NEEDING A CONTRACT PACKAGER 22

TABLE 8 (CONTINUED) 23

SELECTING A CONTRACT PACKAGER 23

TABLE 9 KEY CHARACTERISTICS IN SELECTING A CONTRACT

PACKAGER 24

HIRING A CONTRACT PACKAGER 24

TABLE 10 KEY STEPS IN HIRING A CONTRACT PACKAGER 25

TYPES OF PACKAGING 25

TYPES OF PACKAGING (CONTINUED) 26

CHAPTER SEVEN: PROJECT MANAGEMENT 27

SPECIFICATIONS OF PROJECT MANAGEMENT 27

TABLE 11 STEPS OF PROJECT MANAGEMENT 27

TABLE 11 (CONTINUED) 28

PROCESSES OF PROJECT MANAGEMENT 28

TABLE 12 PROCESSES OF PROJECT MANAGEMENT 28

TABLE 12 (CONTINUED) 29

FACTORS INVOLVED 29

ROLE OF THE PROJECT MANAGER 29

TABLE 13 KEY RESPONSIBILITIES OF PROJECT MANAGERS 30

TECHNOLOGY TRANSFER 30

TABLE 14 TECHNOLOGY TRANSFER STEPS 31

CHAPTER EIGHT: REGULATORY ASPECTS 32

REGULATORY ASPECTS 32

TABLE 15 REGULATED FACTORS OF CMO'S AND CRO'S 33

TABLE 16 TITLE 21 CFR RULES ASSOCIATED WITH CONTRACT

MANUFACTURING 33

TABLE 16 (CONTINUED) 34

TABLE 16 (CONTINUED) 35

WARNING LETTERS 36

TABLE 17 WARNING LETTERS ISSUED TO CONTRACT

MANUFACTURERS, 2010 36

TABLE 18 WARNING LETTERS ISSUED TO CONTRACT

MANUFACTURERS, 2009 37

REGULATORY APPROVALS 37

TABLE 19 REGULATORY APPROVALS OF CONTRACT

MANUFACTURERS AND FACILITIES, JANUARY THROUGH

MARCH, 2011 38

TABLE 20 REGULATORY APPROVALS OF CONTRACT

MANUFACTURERS AND FACILITIES, 2010 38

TABLE 20 (CONTINUED) 39

TABLE 21 REGULATORY APPROVALS OF CONTRACT

MANUFACTURERS AND FACILITIES, 2009 39

TABLE 21 (CONTINUED) 40

CHAPTER NINE: INDUSTRY STRUCTURE FOR EMERGING MARKETS 41

MARKET SHARE OF INDUSTRY LEADERS 41

CONTRACT MANUFACTURERS OF BULK DRUGS AND API'S 41

TABLE 22 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING BULK DRUGS/API'S, IN REST OF

WORLD, 2010 (%) 42

FIGURE 1 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING BULK DRUGS/API'S, IN REST OF

WORLD, 2010 (%) 42

CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS 43

TABLE 23 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SOLID DOSAGE FORMS, 2010 (%) 43

FIGURE 2 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SOLID DOSAGE FORMS, IN REST OF

WORLD, 2010 (%) 44

CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS 44

NONSTERILE 44

TABLE 24 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS,

IN REST OF WORLD, 2010 (%) 45

FIGURE 3 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS,

IN REST OF WORLD, 2010 (%) 45

STERILE 46

TABLE 25 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN

REST OF WORLD, 2010 (%) 46

FIGURE 4 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN

REST OF WORLD, 2010 (%) 47

CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS 47

TABLE 26 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN REST

OF WORLD, 2010 (%) 48

FIGURE 5 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN REST

OF WORLD, 2010 (%) 48

CONTRACT RESEARCH COMPANIES 48

TABLE 27 MARKET SHARES OF CONTRACT RESEARCH

COMPANIES, IN REST OF WORLD, 2010 (%) 49

FIGURE 6 MARKET SHARES OF CONTRACT RESEARCH

COMPANIES, IN REST OF WORLD, 2010 (%) 49

CONTRACT PACKAGING COMPANIES 50

TABLE 28 MARKET SHARE OF CONTRACT PACKAGING

COMPANIES, IN REST OF WORLD, 2010 (%) 50

FIGURE 7 MARKET SHARE OF CONTRACT PACKAGING

COMPANIES, IN REST OF WORLD, 2010 (%) 51

TYPES OF CONTRACT MANUFACTURING AND RESEARCH

FIRMS 51

TABLE 29 SERVICES PROVIDED BY CONTRACT MANUFACTURING

AND RESEARCH FIRMS 52

TABLE 29 (CONTINUED) 53

TABLE 30 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS

BY PACKAGING TYPE 54

CHAPTER TEN: TECHNOLOGY TRANSFER 55

REASONS FOR TECHNOLOGY TRANSFER 55

CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER 56

TECHNOLOGY TRANSFER 57

STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER 57

TYPES OF CONTRACTUAL AGREEMENTS USED IN

TECHNOLOGY TRANSFER 58

CONFIDENTIAL DISCLOSURE AGREEMENT (CDA) 59

MATERIAL TRANSFER AGREEMENT (MTA) 59

ASSIGNMENT DEED 59

LICENSE AGREEMENT 60

CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS 60

CHARACTERISTICS OF A SUCCESSFUL PROJECT 60

CHARACTERISTICS OF A SUCCESSFUL … (CONTINUED) 61

CHAPTER ELEVEN: NEW DEVELOPMENTS 62

LONZA 62

ABBOTT 63

HOSPIRA 64

COVIDIEN 64

OTHER 65

OTHER (CONTINUED) 66

CHAPTER TWELVE: MARKET ANALYSIS FOR REST OF

WORLD/EMERGING MARKETS 67

CONTRACT MANUFACTURING 67

CONTRACT MANUFACTURE OF BULK DRUGS/API'S 67

Market Overview 67

Market Revenue 68

TABLE 31 REST OF WORLD BULK DRUG/API'S CONTRACT

MANUFACTURING REVENUE, THROUGH 2016 ($ BILLIONS) 69

FIGURE 8 REST OF WORLD BULK DRUG/API'S CONTRACT

MANUFACTURING REVENUE, 2009-2016 ($ BILLIONS) 69

CONTRACT MANUFACTURE OF ORAL DOSAGE

FORMULATIONS* 69

Solid Dosage Formulations 70

Market Overview 70

Market Revenue 71

TABLE 32 SOLID DOSAGE FORM CONTRACT MANUFACTURING,

FOR REST OF WORLD, THROUGH 2016 ($ BILLIONS) 71

FIGURE 9 SOLID DOSAGE FORM CONTRACT MANUFACTURING,

FOR REST OF WORLD, 2009-2016 ($ BILLIONS) 72

Market by Formulation 72

Market Revenue 72

TABLE 33 SOLID DOSAGE FORM CONTRACT MANUFACTURING

REVENUE, BY FORMULATION, FOR REST OF WORLD,

THROUGH 2016 ($ BILLIONS) 73

FIGURE 10 SOLID DOSAGE FORM CONTRACT MANUFACTURING

REVENUE, BY FORMULATION, FOR REST OF WORLD, 2009-2016

($ BILLIONS) 73

TABLE 34 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARE, BY FORMULATION, FOR REST OF WORLD,

2010 (%) 74

FIGURE 11 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARE BY FORMULATION, FOR REST OF WORLD, 2010

(%) 74

Liquid Dosage Formulation 75

Market Overview 75

Market Revenue 75

Nonsterile Formulations 75

TABLE 35 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING FOR REST OF WORLD, THROUGH 2016 ($

MILLIONS) 76

FIGURE 12 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING FOR REST OF WORLD, 2009-2016 ($

MILLIONS) 76

Sterile Formulations 77

TABLE 36 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING, FOR REST OF WORLD, THROUGH 2016 ($

MILLIONS) 77

FIGURE 13 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING, FOR REST OF WORLD, 2009-2016 ($

MILLIONS) 77

Market by Formulation 78

Nonsterile Formulations 78

TABLE 37 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF

WORLD, THROUGH 2016 ($ MILLIONS) 78

FIGURE 14 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF

WORLD, 2009-2016 ($ MILLIONS) 79

TABLE 38 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 79

FIGURE 15 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 80

Sterile Formulations 80

TABLE 39 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING REVENUE BY FORMULATION FOR REST OF

WORLD, THROUGH 2016 ($ MILLIONS) 81

FIGURE 16 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING REVENUE BY FORMULATION, FOR REST OF

WORLD, 2009-2016 ($ MILLIONS) 81

TABLE 40 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 82

FIGURE 17 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 82

CONTRACT MANUFACTURE OF SEMISOLID DOSAGE

FORMULATIONS 82

Market Overview 82

Market Revenue 83

TABLE 41 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING, FOR REST OF WORLD, THROUGH 2016 ($

MILLIONS) 84

FIGURE 18 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING, FOR REST OF WORLD, 2009-2016 ($

MILLIONS) 84

Market by Formulation 84

TABLE 42 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING REVENUE BY FORMULATION, FOR REST OF

WORLD, THROUGH 2016 ($ MILLIONS) 85

FIGURE 19 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING REVENUE BY FORMULATION, FOR REST OF

WORLD, 2009-2016 ($ MILLIONS) 85

TABLE 43 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARE BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 86

FIGURE 20 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARE BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 86

CONTRACT MANUFACTURE OF ADVANCED DRUG

DELIVERY PRODUCTS 86

Market Overview 87

TABLE 44 CONTRACTING COMPANIES PROVIDING DRUG

DELIVERY SYSTEMS IN ROW 88

TABLE 45 ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY

CONTRACT MANUFACTURING, FOR REST OF WORLD,

THROUGH 2016 ($ BILLIONS) 88

FIGURE 21 ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY

CONTRACT MANUFACTURING, FOR REST OF WORLD,

THROUGH 2016 ($ BILLIONS) 89

Market by Formulation 89

TABLE 46 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF

WORLD, THROUGH 2016 ($ MILLIONS) 90

FIGURE 22 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF

WORLD, 2009-2016 ($ MILLIONS) 90

Market Share 91

TABLE 47 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 91

FIGURE 23 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 92

CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL

PRODUCTS 92

Market Revenue 93

TABLE 48 OTC AND NUTRITIONAL PRODUCTS REVENUE BY

CONTRACT MANUFACTURING, FOR REST OF WORLD,

THROUGH 2016 ($ BILLIONS) 94

FIGURE 24 OTC AND NUTRITIONAL PRODUCTS REVENUE BY

CONTRACT MANUFACTURING, FOR REST OF WORLD, 2009-2016

($ BILLIONS) 94

TABLE 49 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF

WORLD, THROUGH 2016 ($ BILLIONS) 95

FIGURE 25 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATIONS, FOR REST

OF WORLD, 2009-2016 ($ BILLIONS) 96

Market Shares 96

TABLE 50 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 96

FIGURE 26 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2009-2016 (%) 97

CONTRACT RESEARCH 97

MARKET OVERVIEW 97

Partnerships 97

Expansions of Facilities 98

Market Revenue 99

TABLE 51 CONTRACT RESEARCH REVENUE FOR REST OF WORLD,

THROUGH 2016 ($ BILLIONS) 99

FIGURE 27 CONTRACT RESEARCH REVENUE FOR REST OF

WORLD, 2009-2016 ($ BILLIONS) 100

Market by Discipline 100

TABLE 52 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

REST OF WORLD, THROUGH 2016 ($ BILLIONS) 101

FIGURE 28 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

REST OF WORLD, 2009-2016 ($ BILLIONS) 101

Market Shares by Discipline 102

TABLE 53 CONTRACT RESEARCH MARKET SHARE BY DISCIPLINE,

FOR REST OF WORLD, 2010 (%) 102

FIGURE 29 CONTRACT RESEARCH MARKET SHARE BY

DISCIPLINE, FOR REST OF WORLD, 2010 (%) 102

CONTRACT PACKAGING 103

MARKET OVERVIEW 103

TABLE 54 CONTRACT PACKAGING REVENUE, FOR REST OF

WORLD, THROUGH 2016 ($ BILLIONS) 104

FIGURE 30 CONTRACT PACKAGING REVENUE, FOR REST OF

WORLD, 2009-2016 ($ BILLIONS) 104

Market by Package Type 104

Market Revenue 105

TABLE 55 CONTRACT PACKAGING REVENUE BY TYPE, FOR REST

OF WORLD, THROUGH 2016 ($ MILLIONS) 105

FIGURE 31 CONTRACT RESEARCH REVENUE BY DISCIPLINE FOR

REST OF WORLD, THROUGH 2016 ($ MILLIONS) 106

Market Share by Type 106

TABLE 56 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR

REST OF WORLD, 2010 (%) 107

FIGURE 32 CONTRACT PACKAGING MARKET SHARE BY TYPE,

FOR REST OF WORLD, 2010 (%) 107

CHAPTER THIRTEEN: MARKET SHARE BY REGION 108

MARKET SHARE OF CONTRACT MANUFACTURED API'S 108

TABLE 57 BULK DRUG/API CONTRACT MANUFACTURING

MARKET SHARE, BY REGION, 2010 (%) 108

FIGURE 33 BULK DRUG/API CONTRACT MANUFACTURING

MARKET SHARE, BY REGION, 2010 (%) 109

MARKET SHARE OF CONTRACT MANUFACTURED SOLID

DOSAGE FORMS 109

TABLE 58 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARE, BY REGION, 2010 (%) 109

FIGURE 34 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARE, BY REGION, 2010 (%) 110

MARKET SHARE OF CONTRACT MANUFACTURED LIQUID

DOSAGE FORMULATIONS 110

NONSTERILE FORMULATIONS 110

TABLE 59 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 110

FIGURE 35 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 111

STERILE FORMULATIONS 111

TABLE 60 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 111

FIGURE 36 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 112

MARKET SHARE OF CONTRACT MANUFACTURED SEMISOLID

DOSAGE FORMULATIONS 112

TABLE 61 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARES, BY REGION, 2010 (%) 112

FIGURE 37 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 113

MARKET SHARE OF CONTRACT MANUFACTURED ADVANCED

DRUG DELIVERY PRODUCTS 113

TABLE 62 DRUG DELIVERY CONTRACT MANUFACTURING

MARKET SHARE, BY REGION, 2010 (%) 113

FIGURE 38 DRUG DELIVERY CONTRACT MANUFACTURING

MARKET SHARE, BY REGION, 2010 (%) 114

MARKET SHARE OF CONTRACT MANUFACTURED OTC AND

NUTRITIONAL PRODUCTS 114

TABLE 63 OTC AND NUTRITIONAL PRODUCTS CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 114

FIGURE 39 OTC AND NUTRITIONAL PRODUCT CONTRACT

MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 115

MARKET SHARE OF CONTRACT RESEARCH 115

TABLE 64 CONTRACT RESEARCH MARKET SHARE, BY REGION,

2010 (%) 115

FIGURE 40 CONTRACT RESEARCH MARKET SHARE, BY REGION,

2010 (%) 116

MARKET SHARE OF CONTRACT PACKAGING 116

TABLE 65 CONTRACT PACKAGING MARKET SHARE, BY REGION,

2010 (%) 116

FIGURE 41 CONTRACT PACKAGING MARKET SHARE, BY REGION,

2010 (%) 117

CHAPTER FOURTEEN: CONTRACT MANUFACTURING APPLICATIONS

FOR REST OF THE WORLD (ROW) 118

CARDIOVASCULAR DRUGS 118

MARKET REVENUE 119

TABLE 66 REVENUE FROM CONTRACT MANUFACTURERS OF

CARDIOVASCULAR DRUGS, IN REST OF WORLD, THROUGH 2016

($ MILLIONS) 119

FIGURE 42 REVENUE FROM CONTRACT MANUFACTURERS OF

CARDIOVASCULAR DRUGS, IN REST OF WORLD, 2009-2016 ($

MILLIONS) 120

REPRODUCTIVE DRUG MARKET 120

MARKET REVENUE 121

TABLE 67 REVENUE FROM CONTRACT MANUFACTURERS OF

REPRODUCTIVE DRUGS, IN REST OF WORLD, THROUGH 2016 ($

MILLIONS) 122

FIGURE 43 REVENUE FROM CONTRACT MANUFACTURERS OF

REPRODUCTIVE DRUGS, IN REST OF WORLD, 2009-2016 ($

MILLIONS) 122

ONCOLOGY DRUG MARKET 122

MARKET REVENUE 123

TABLE 68 REVENUE FROM CONTRACT MANUFACTURERS OF

DRUGS USED IN ONCOLOGY, IN REST OF WORLD, THROUGH

2016 ($ MILLIONS) 124

FIGURE 44 REVENUE FROM CONTRACT MANUFACTURERS OF

DRUGS USED IN ONCOLOGY, IN REST OF WORLD, 2009-2016 ($

MILLIONS) 124

ANALGESICS MARKET 124

MARKET REVENUE 125

TABLE 69 REVENUE FROM CONTRACT MANUFACTURERS OF

ANALGESICS, IN REST OF WORLD, THROUGH 2016 ($

MILLIONS) 125

FIGURE 45 REVENUE FROM CONTRACT MANUFACTURERS OF

ANALGESICS, IN REST OF WORLD, 2009-2016 ($ MILLIONS) 126

ANTIVIRAL DRUG MARKET 126

MARKET REVENUE 127

TABLE 70 REVENUE FROM CONTRACT MANUFACTURERS OF

ANTIVIRALS, IN REST OF WORLD, THROUGH 2016 ($

MILLIONS) 127

FIGURE 46 REVENUE FROM CONTRACT MANUFACTURERS OF

ANTIVIRALS, IN REST OF WORLD, 2009-2016 ($ MILLIONS) 127

ANTIBIOTICS MARKET 128

MARKET REVENUE 128

TABLE 71 REVENUE FROM CONTRACT MANUFACTURERS OF

ANTIBIOTICS, IN REST OF WORLD, THROUGH 2016 ($

MILLIONS) 128

FIGURE 47 REVENUE FROM CONTRACT MANUFACTURERS OF

ANTIBIOTICS, IN REST OF WORLD, 2009-2016 ($ MILLIONS) 129

MARKETS FOR OTHER DRUGS 129

MARKET REVENUE 130

TABLE 72 REVENUE FROM CONTRACT MANUFACTURERS OF

OTHER DRUGS, IN REST OF WORLD, THROUGH 2016 ($

BILLIONS) 130

FIGURE 48 REVENUE FROM CONTRACT MANUFACTURERS OF

OTHER DRUGS, IN REST OF WORLD, 2009-2016 ($ BILLIONS) 130

CHAPTER FIFTEEN: PATENT ANALYSIS 131

PATENTS BY YEAR 131

TABLE 73 NUMBER OF SIGNIFICANT PATENTS, BY YEAR, 2009-

2011 131

FIGURE 49 NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011 131

FIGURE 50 NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011 (%) 132

PATENTS BY COMPANY 132

TABLE 74 NUMBER OF US PATENTS, BY COMPANY, 2009-2011 133

FIGURE 51 NUMBER OF US PATENTS, BY COMPANY, 2009-2011 134

PATENTS BY COUNTRY 135

TABLE 75 NUMBER OF US PATENTS, BY COUNTRY, 1/1/2009 TO

5/31/2011 135

FIGURE 52 NUMBER OF US PATENTS, BY COUNTRY, 1/1/2009 TO

5/31/2011 136

TABLE 76 PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011

(%) 136

FIGURE 53 PATENT SHARES, BY COUNTRY, 1/1/2009 TO

5/31/2011 (%) 137

PATENTS BY EMPHASIS 137

TABLE 77 PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011 138

FIGURE 54 NUMBER OF US PATENTS, BY EMPHASIS, 1/1/2009 TO

5/31/2011 138

CHAPTER SIXTEEN: CURRENT ENVIRONMENT 139

SITUATION OF THE NORTH AMERICAN CONTRACTING

MARKETS 139

CONTRACT MANUFACTURING OF API AND DOSAGE

FORMS 139

CONTRACT MANUFACTURING OF OTC AND

NUTRACEUTICALS 139

CONTRACT RESEARCH 140

CONTRACT PACKAGING 140

SITUATION OF THE EUROPEAN CONTRACTING MARKET 140

CONTRACT MANUFACTURING OF API AND DOSAGE

FORMS 140

CONTRACT MANUFACTURING OF OTC AND

NUTRACEUTICALS 140

CONTRACT RESEARCH 141

CONTRACT PACKAGING 141

SITUATION OF THE ROW CONTRACTING MARKET 141

CONTRACT MANUFACTURING OF API AND DOSAGE

FORMS 141

CONTRACT MANUFACTURING OF OTC AND

NUTRACEUTICALS 141

CONTRACT RESEARCH 142

CONTRACT PACKAGING 142

OPPORTUNITIES AND CHALLENGES OF THE CURRENT

CONTRACT MANUFACTURING INDUSTRY 142

OPPORTUNITIES AND CHALLENGES…(CONTINUED) 143

OPPORTUNITIES AND CHALLENGES…(CONTINUED) 144

CHAPTER SEVENTEEN: COMPANY PROFILES 145

AAI PHARMA, INC 145

ABBOTT LABORATORIES 145

AEROGEN LTD 146

ALKERMES 146

ALTHEA TECHNOLOGIES 147

AMCOR 148

AMERISOURCE BERGEN CORPORATION 148

AMPAC FINE CHEMICALS 149

ALBANY MOLECULAR RESEARCH INC (AMRI) 149

AP PHARMA INC 150

APTUIT INC 150

ARADIGM CORPORATION 151

BASF SE 152

BAXTER HEALTHCARE 152

BCM/BOOTS MANUFACTURING 153

BOEHRINGER INGELHEIM 154

BRISTOL-MYERS SQUIBB 154

CAMBREX CORPORATION 155

CANGENE CORPORATION 156

CATALENT PHARMA SOLUTIONS 156

CEDARBURG HAUSER PHARMACEUTICALS INC 157

CENEXI 157

CHARLES RIVER LABORATORIES 158

CHEMBRIDGE CORP 158

CLEARSTONE CENTRAL LABORATORIES 159

CONFAB LABORATORIES 159

COVANCE INC 160

COVIDIEN 160

CONTRACT PHARMACEUTICALS LIMITED 161

CORDEN PHARMA SWITZERLAND LLC 161

DAVOS PHARMA 162

DECODE GENETICS 162

DISHMAN PHARMACEUTICALS AND CHEMICALS LTD 163

DOW CHEMICAL 164

DPT LABORATORIES INC 164

DR REDDY'S LABORATORIES 165

DSM PHARMACEUTICAL PRODUCTS 165

FUJIFILM DIOSYNTH BIOTECHNOLOGY 166

ELAN DRUG TECHNOLOGIES 166

EVOTEC AG 167

FULCRUM PHARMA PLC 167

GIRINDUS AG 168

GLAXOSMITHKLINE 168

HOSPIRA 169

HAUPT PHARMA AG 170

HOVIONE SA 170

ICON PLC 171

INC RESEARCH, INC 171

JUBILANT LIFESCIENCES 172

KENDLE INTERNATIONAL INC 172

KP PHARMACEUTICAL TECHNOLOGIES INC 173

KV PHARMACEUTICAL CO 173

LIGAND PHARMACEUTICALS, INC 174

LONZA GROUP 174

LYNE LABORATORIES 175

MERCK / MSD BIOMANUFACTURING NETWORK 176

MIKART INC 176

NEXTPHARMA TECHNOLOGIES 177

NORWICH PHARMACEUTICALS 177

NOVAVAX, INC 178

OMNICARE CLINICAL RESEARCH 178

PAREXEL INTERNATIONAL CORPORATION 179

PATHEON INC 179

PERRIGO COMPANY 180

PFIZER (KING PHARMACEUTICALS 181

PIRAMAL HEALTHCARE LIMITED 181

PPD 182

PRA INTERNATIONAL 182

QUINTILES 183

RANBAXY 183

REGIS TECHNOLOGIES, INC 184

SKYEPHARMA 184

TALECRIS BIOTHERAPEUTICS INC 185

VETTER PHARMA INTERNATIONAL GMBH 185

WOCKHARDT LIMITED 186

WUXI APP TEC 187

XCELLEREX LLC 187

ZACH SYSTEM SPA 188

APPENDIX I: ABBREVIATIONS 189

To order this report:

Manufacturing Industry: Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets

Manufacturing Business News

More  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Generic Drugs: The Global Market--Focus on Europe
2. Generic Drugs: The Global Market--Focus on Asia
3. Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets
4. Commonwealth Welcomes Global Commitment to Combat Non-Communicable Diseases
5. Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on North America
6. Generic Drugs: The Global Market
7. Generic Drugs: The Global Market: Focus on the Americas
8. Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe
9. Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
10. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on September 28, 2011
11. Accuray Incorporated to Speak at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):